Abstract
From about 1930 to the late 1960s a definition of addiction dominated in the United States that made opiate-style abstinence reactions essential, and distinguished sharply between true addiction and merely psychological drug habituation. This definition was so narrow that it left all stimulants out of the addictive category, and it was not uncontested. By looking at the postwar efforts of one of the chief architects of this definition, pharmacologist Maurice Seevers, to defend his conception of addiction in both scientific and policy realms, I demonstrate the contingency of this construction of addiction upon methodological commitments and industrial interests related to amphetamines and tobacco.
Similar content being viewed by others
Notes
These methods were transmitted to the tobacco industry before their publication, via pharmacologist Harvey Haag; Seevers to Haag, 25 January 1950, http://legacy.library.ucsf.edu/tid/kxi54f00 (Bates 950163678). I have found no discussion of nicotine pharmacology research in Seevers’ publications from the 1950s, despite his development of the methods.
E.S. Harlow to H.R. Hanmer, W.R. Harlan, 17 February 1954, http://legacy.library.ucsf.edu/tid/ycr94f00 (Bates 961007771/7772); Harlow to Hamner, ‘Possible Animal Experiments On Cigarette Smoke Tars,’ 20 April 1955, http://legacy.library.ucsf.edu/tid/atf34f00 (Bates 962006662).
Harlow? [‘H’] memo, 8 March 1960, http://legacy.library.ucsf.edu/tid/fgu60a00 (Bates 966027156).
Lovell White, 20 June 1994, ‘Re: Historical Overview of Definitions of Addiction/Dependence’, http://legacy.library.ucsf.edu/tid/bbc73a99 (Bates 3421418609-321418625).
Harlow? [‘H’] 8 March 1960, http://legacy.library.ucsf.edu/tid/fgu60a00 (Bates 966027156); Harlow to Hanmer and Harlan, 8 March 1960, ‘re American Medical Association's Stand on Cigarette Smoking-Lung Cancer Controversy’, http://legacy.library.ucsf.edu/tid/nel31a00 (Bates 950140808).
Hanmer to Harlow, Harlan, 27 March 1962, memo re ‘Discussion with Dr MH Seevers, March 27, 1962, of Means for Obtaining Publicity of Cohen-Heimann Article’, http://legacy.library.ucsf.edu/tid/qbx31a00 (Bates 950277243); Harlow to Hamner and Harlan, 29 May 1962, memo re ‘Impending Action by the AMA on Lung Cancer Controversy. Report of Telephone Conversation with Dr MH Seevers today’, http://legacy.library.ucsf.edu/tid/hel31a00 (Bates 950140798).
Seevers to Harlow, 22 March 1962, http://legacy.library.ucsf.edu/tid/cnh54f00 (Bates 950167102); Harlow to Hanmer, 25 June 1965, memo ‘Developments Regarding the action of the AMA on the smoking and health controversy. Reference: Conversation with Dr MH Seevers at the Roger Smith Hotel in Washington, DC, Sunday, June 24, 1962’, http://legacy.library.ucsf.edu/tid/zdl31a00 (Bates 950140786/0787).
Harlow to Hanmer, Harlan, 2 October 1962, ‘re US Public Health Service Panel for Study of the Tobacco and Health Situation. Reference: Telephone Conversation with Dr Seevers 10/1/62’, http://legacy.library.ucsf.edu/tid/qdl31a00 (Bates 950140771).
Interview with Leonard Schumann, 15 July 1988, http://legacy.library.ucsf.edu/tid/mto34c00 (Bates 83724687/4688).
Oral Deposition of Charles LeMaistre, 20 August 1997, Texas v. American Tobacco, Civil Action 5-96CV91, http://legacy.library.ucsf.edu/tid/qks07a00 (Bates LEMAISTREC082097), pp. 144–186.
Schumann interview, p. 10; Bayne-Jones (with LeMaistre) to Francis Blasingame, 2 July 1968, http://legacy.library.ucsf.edu/tid/evq57a00 (Bates LG0047055-LG0047057).
Seevers’ (1962) ‘psychotoxicity’ appears in the NRC addiction group's précis of the 1964–1965 WHO redefinition, but not in the 1965 WHO document itself (Eddy et al, 1965; WHO, 1965). The term never gained any official status as far as I am aware.
Anon, 1 October 1964 ‘Conversation with Dr Seevers, Ann Arbor, Michigan’, http://legacy.library.ucsf.edu/tid/ole94a99 (Bates 105610974-105610978). In 1968, Seevers was still publicly defending the late 1950s version of the dual action theory. The work cited by a former student as Seever's retraction of the theory (Cochin, 1970) actually only renounces the original 1929 dual-action theory (Seevers and Deneau, 1968).
‘Conversation with Dr Seevers, Ann Arbor, Michigan’. Quote from A. Yeaman, 17 July 1963, ‘Implications Of Battelle Hippo I & II And The Griffith Filter’, http://legacy.library.ucsf.edu/tid/xrc72d00 (Bates 1802.05). Tobacco scientists worried that lower nicotine might free smokers of their ‘entrenched [drug] habit’ as early as 1959; RDW, June 1959, ‘Complexity of the PA5A Machine and Variables Pool’, http://legacy.library.ucsf.edu/tid/fnb32a99 (Bates 100099115-100099117) (see Hirschhorn, forthcoming).
G.H. Hall, 26 February 1968, ‘Role of Nicotine in Health. Report on a Conversation with Dr MH Seevers’, http://legacy.library.ucsf.edu/tid/tnu82a99 (Bates 100182204-100182206).
I am thinking especially of the experts providing the science, diagnostic guidelines and treatment standards in fields more highly commercialized than substance abuse, such as attention deficit and mood disorders (see Cosgrove et al, 2006).
References
Acker, C.J. (2002) Creating the American Junkie: Addiction Research in the Classic Era of Narcotic Control. Baltimore, MD: Johns Hopkins University Press.
AMA Committee on Alcoholism and Addiction and Council on Mental Health. (1966) Dependence on amphetamines and other stimulant drugs. JAMA – Journal of the American Medical Association 197: 1023–1027.
Becker, H.S. (1963) Outsiders: Studies in the Sociology of Deviance. New York: Free Press.
Berridge, V. (1979) Morality and medical science: Concepts of narcotic addiction in Britain, 1820–1926. Annals of Science 36: 67–85.
Berridge, V. (2007) Medicine and the public: The 1962 report of the Royal College of Physicians and the new public health. Bulletin of the History of Medicine 81: 286–311.
Berridge, V. (2009) Smoking and the ‘discovery of addiction’. Paper presented at the Conference on Addiction, the Brain, and Society; February 2009, Emory University.
Blasingame, F.J.L. (1964) Full text of AMA letter of testimony to FTC. JAMA – Journal of the American Medical Association 188: 31.
Brandon, S. and Smith, D. (1962) Amphetamines in general practice. Journal of the College of General Practitioners 5: 603–606.
Brandt, A.M. (2007) The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product that Defined America. New York: Basic Books.
Campbell, N.D. (2007) Discovering Addiction: The Science and Politics of Substance Abuse Research. Ann Arbor, MI: University of Michigan Press.
Cochin, J. (1970) Biochemical aspects of tolerance. University of Michigan Medical Center Journal 36 (2): 225–233.
Cosgrove, L., Krimsky, S., Vijayaraghavan, M. and Schneider, L. (2006) Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics 75: 154–160.
Courtwright, D.T. (1982) Dark Paradise: Opiate Addiction in America before 1940. Cambridge: Harvard University Press.
Courtwright, D.T. (1989) Introduction: The classic era of narcotic control. In: D.T. Courtwright, H. Joseph and D. Des Jarlais (eds.) Addicts Who Survived: An Oral History of Narcotics Use in America, 1923–1965. Knoxville, TN: University of Tennessee Press, pp. 1–44.
Denau, G., Yanagita, T. and Seevers, M. (1969) Self-administration of psychoactive substances by the monkey: A measure of psychological dependence. Psychopharmacologia 16: 30–48.
Deneau, G. (1970) The monkey colony in studies of tolerance and dependence. University of Michigan Medical Center Journal 36 (2): 212–214.
Doll, R. and Hill, A.B. (1954) The mortality of doctors in relation to their smoking habits: A preliminary report. British Medical Journal 1: 1541–1555.
Doll, R. and Hill, A.B. (1956) Lung cancer and other causes of death in relation to smoking: A second report on the mortality of British doctors. British Medical Journal 2: 1071–1081.
Doll, R., Peto, R., Boreham, J. and Sutherland, I. (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. British Medical Journal 328(7455): 1519–1527.
Eddy, N., Halbach, H., Isbell, H. and Seevers, M. (1965) Drug dependence, its significance and characteristics. Bulletin of the World Health Organization 32: 721–733.
Eddy, N. and Reid, J.G. (1934) Studies of morphine, codeine, and derivatives. VII. Dihydromorphine (paramorphan), dihydromorphinone (dilaudid), and dihydrocodeinone (dicodide). Journal of Pharmacology and Experimental Therapeutics 52: 468–493.
Goffman, E. (1963) Stigma: Notes on the Management of Spoiled Identity. New York: Prentice-Hall.
Hammond, E.C. and Horn, D. (1954) The relationship between human smoking habits and death rates: A follow-up study of 187 766 men. JAMA – Journal of the American Medical Association 155: 1316–1327.
Himmelsbach, C.K. (1943) Can the euphoric, analgetic, and physical dependence effects of drugs be separated? IV. With reference to physical dependence. Federation Proceedings 2: 201–203.
Himmelsbach, C.K., Gerlach, G.H. and Stanton, E.J. (1935) A method for testing addiction, tolerance, and abstinence in the rat. Journal of Pharmacology and Experimental Therapeutics 53: 179–188.
Hirschhorn, N. (forthcoming) Evolution of the Tobacco Industry Positions on Addiction to Nicotine. Geneva, Switzerland: World Health Organization, in press.
Jonnes, J. (1995) The rise of the modern addict. American Journal of Public Health 85: 1157–1162.
Kiloh, L.G. and Brandon, S. (1962) Habituation and addiction to amphetamines. British Medical Journal 1: 40–43.
Kluger, R. (1996) Ashes to Ashes: America's Hundred-year Cigarette War, the Public Health, and the Unabashed Triumph of Philip Morris. New York: Knopf.
Kolb, L. (1939) Drug addiction as a public health problem. Scientific Monthly (May): 391–400.
Kolb, L. and DuMez, A.G. (1924) The prevalence and trend of drug addiction in the United States and factors influencing it. Public Health Reports 39: 1179–1204.
Kolb, L. and DuMez, A.G. (1931) Experimental addiction of animals to opiates. Public Health Reports 46: 698–726.
Levine, H. (1978) The discovery of addiction: Changing conceptions of habitual drunkenness in America. Journal of Studies on Alcohol 15: 493–506.
Lindesmith, A.R. (1940) The drug addict as a psychopath. American Sociological Review 5: 914–920.
Mars, S.G. and Ling, P.M. (2008) Meanings & motives. Experts debating tobacco addiction. American Journal of Public Health 98: 1793–1802.
Musto, D. (1973) The American Disease: Origins of Narcotic Control. New Haven, CT: Yale University Press.
Oswald, I. and Thacore, V.R. (1963) Amphetamine and phenmetrazine addiction. British Medical Journal 2: 427–431.
Parascandola, M. (2009) Nicotine regulation and tobacco harm reduction. Paper presented at the Addiction, the Brain and Society Conference, Emory University, Atlanta, GA.
Peele, S. (1977) Redefining addiction: Making addiction a scientifically and socially useful concept. International Journal of Health Services 7: 103–124.
Pieters, T. and Snelders, S. (2007) From King Kong pills to mother's little helpers: Career cycles of two families of psychotropic drugs: The barbiturates and benzodiazepines. Canadian Bulletin of Medical History 24: 93–112.
Rasmussen, N. (2004) The moral economy of the drug company-medical scientist collaboration in interwar America. Social Studies of Science 34: 161–186.
Rasmussen, N. (2005) The commercial drug trial in interwar America: Three types of clinician collaborator. Bulletin of the History of Medicine 75: 50–80.
Rasmussen, N. (2008a) On Speed: The Many Lives of Amphetamine. New York: New York University Press.
Rasmussen, N. (2008b) America's first amphetamine epidemic, 1929–1971: A quantitative and qualitative retrospective. American Journal of Public Health 98: 974–985.
Rose, N. (2004) Becoming neurochemical selves. In: N. Stehr (ed.) Biotechnology: Between Commerce and Civil Society. New Brunswick, NJ: Transaction Press.
Royal College of Physicians of London. (1962) Smoking and Health. London: Pitman.
Schmidt, C.R., Pearson, M.M., Seevers, M.H. and Starr, I. (1961) Medical correlation clinics. 12: Drug addiction. American Practitioner Digest 12: 863–877.
Sedgwick, E.K. (1993) Epidemics of the will. In: Tendencies. Durham, NC: Duke University Press, pp. 130–142.
Seevers, M. (1936a) Opiate addiction in the monkey. I. Methods of study. Journal of Pharmacology and Experimental Therapeutics 56: 147–156.
Seevers, M. (1936b) Opiate addiction in the monkey. II. Dilaudid in comparison with morphine, Heroine, and Codeine. Journal of Pharmacology and Experimental Therapeutics 56: 157–165.
Seevers, M. (1948) Animal experimentation in studying addiction to the newer synthetic analgesics. New York Academy of Sciences 51: 98–105.
Seevers, M. (1953) Perspective versus caprice in evaluating toxicity of chemicals in man. JAMA – Journal of the American Medical Association 153: 1329–1332.
Seevers, M. (1954) Adaptation to narcotics. Federation Proceedings 13: 672–684.
Seevers, M. (1958) Termination of drug action by tolerance development. Federation Proceedings 17: 1175–1181.
Seevers, M. (1962) Medical perspectives on habituation and addiction. JAMA – Journal of the American Medical Association 181: 112–118.
Seevers, M. (1968) Psychopharmacological elements of drug dependence. JAMA – Journal of the American Medical Association 206: 1263–1275.
Seevers, M. (1969) Drugs, monkeys, and men. Michigan Quarterly Review 8: 3–14.
Seevers, M. and Deneau, G.A. (1968) A critique of the ‘dual action’ hypothesis of morphine physical dependence. Research Publications of the Association for Research Nervous and Mental Diseases 46: 199–205.
Seevers, M. and Schuster, C.R. (1967) Self-administration of psychoactive drugs by the monkey: A measure of psychological dependence. Science 158: 535.
Seevers, M. and Shideman, F.E. (1941a) Effects of morphine derivates on intermediary metabolism: Influence of morphine, codeine, and thebaine on the activity of several dehydrogenases and on respiration of rat cerebrum. Journal of Pharmacology and Experimental Therapeutics 71: 373–382.
Seevers, M. and Shideman, F.E. (1941b) Effects of morphine derivates on intermediary metabolism: Influence of thiamin deficiency on respiration of skeletal muscle and cocarboxylase content of tissues of normal and chronically morphinized rats. Journal of Pharmacology and Experimental Therapeutics 71: 383–393.
Seevers, M. and Shideman, F.E. (1942) Effects of morphine derivates on intermediary metabolism: Influence of chronic morphine poisoning on oxygen consumption of rat skeletal muscle. Journal of Pharmacology and Experimental Therapeutics 74: 88–94.
Seevers, M. and Tatum, A. (1931) Chronic experimental barbiturate poisoning. Journal of Pharmacology and Experimental Therapeutics 42: 217–231.
Seevers, M. and Woods, L.A. (1953) The phenomena of tolerance. American Journal of Medicine 14: 546–557.
Slade, J., Bero, L.A., Hanauer, P., Barnes, D.E. and Glantz, S.A. (1995) Nicotine and addiction: The Brown and Williamson documents. JAMA – Journal of the American Medical Association 274: 225–233.
Stevenson, T. and Proctor, R. (2008) The secret and soul of Marlboro: Phillip Morris and the origins, spread, and denial of nicotine freebasing. American Journal of Public Health 98: 1184–1194.
Surgeon General's Advisory Committee on Smoking and Health, Office of the Surgeon General. (1964) Smoking and Health. (Public Health Service Publication No. 1103). Washington: US Government Printing Office.
Swann, J. (1988) Academic Scientists and the Pharmaceutical Industry. Baltimore, MD: Johns Hopkins University Press.
Tatum, A. and Seevers, M. (1929) Experimental cocaine addiction. Journal of Pharmacology and Experimental Therapeutics 36: 401–410.
Tatum, A. and Seevers, M. (1931) Theories of drug addiction. Physiological Reviews 11: 107–121.
Tatum, A., Seevers, M. and Collins, K. (1929) Morphine addiction and its physiological interpretation based on experimental evidence. Journal of Pharmacology and Experimental Therapeutics 36: 447–475.
Weeks, J.R. (1962) Experimental morphine addiction: Method for automatic intravenous injections in unrestrained rats. Science 138: 143–144.
Weinberg, D. (1997) Lindesmith on addiction: A critical history of a classic theory. Sociological Theory 15: 150–161.
Wikler, A. (1950) Sites and mechanisms of action of morphine and related drugs in the central nervous system. Pharmacological Reviews 2: 435–506.
Wilson, C.W.M. and Beacon, S. (1964) An investigation into the habituating properties of an amphetamine–barbiturate mixture. British Journal of Addiction 60: 81–92.
Wolinsky, H. and Brune, T. (1994) The Serpent on the Staff: The Unhealthy Politics of the American Medical Association. New York: Putnam.
Woods, L.A., Cochin, J., Fornefeld, E.J., McMahon, F.G. and Seevers, M.H. (1951) The estimation of amines in biological materials with critical data for cocaine and mescaline. Journal of Pharmacology and Experimental Therapeutics 101: 188–199.
World Health Organization. (1950) WHO Expert Committee on Drugs Liable to Produce Addiction: Report on the Second Session. WHO Technical Report Series, 21. Geneva, Switzerland: WHO.
World Health Organization. (1952) WHO Expert Committee on Drugs Liable to Produce Addiction: Third Report. WHO Technical Report Series, 57. Geneva, Switzerland: WHO.
World Health Organization. (1957) WHO Expert Committee on Addiction-producing Drugs: Seventh Report. WHO Technical Report Series, 116. Geneva, Switzerland: WHO.
World Health Organization. (1965) WHO Expert Committee on Dependence-producing Drugs: Fourteenth Report. WHO Technical Report Series, 312. Geneva, Switzerland: WHO.
World Health Organization. (1969) WHO Expert Committee on Dependence-producing Drugs: Sixteenth Report. WHO Technical Report Series, 407. Geneva, Switzerland: WHO.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rasmussen, N. Maurice Seevers, the stimulants and the political economy of addiction in American biomedicine. BioSocieties 5, 105–123 (2010). https://doi.org/10.1057/biosoc.2009.7
Published:
Issue Date:
DOI: https://doi.org/10.1057/biosoc.2009.7